Literature DB >> 3455566

The course of fever during treatment of pulmonary tuberculosis.

P F Barnes1, L S Chan, S F Wong.   

Abstract

We studied 161 patients with pulmonary tuberculosis: 55 (34%) were afebrile and 106 (66%) were febrile at presentation. Febrile patients were younger and more symptomatic than afebrile individuals. Fever was also associated with a higher incidence of lymphopenia, hyponatraemia, hypoalbuminaemia and many acid-fast bacilli on sputum smear. Most patients were treated with isoniazid, rifampicin and pyrazinamide. Of 83 individuals who became afebrile while in hospital, 74 (89%) did so within a week and 77 (93%) in 2 weeks. Prolonged fever was associated with alcoholism, anaemia, hyponatraemia and hypoalbuminaemia. A therapeutic trial of antituberculosis drugs may be more useful than has been previously thought, since in most patients the temperature falls to normal within 2 weeks.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3455566     DOI: 10.1016/0041-3879(87)90065-1

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  5 in total

Review 1.  Quality of life in tuberculosis: a review of the English language literature.

Authors:  Betty Chang; Albert W Wu; Nadia N Hansel; Gregory B Diette
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

Review 2.  Avoidance and management of adverse reactions to antituberculosis drugs.

Authors:  A M Patel; J McKeon
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

3.  Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison.

Authors:  Yong-Jiang Sun; T K Lim; Adrian Kheng Yeow Ong; Benjamin Choon Heng Ho; Geok Teng Seah; Nicholas I Paton
Journal:  BMC Infect Dis       Date:  2006-07-05       Impact factor: 3.090

Review 4.  Risk factors associated with adverse reactions to antituberculosis drugs.

Authors:  Laíse Soares Oliveira Resende; Edson Theodoro Dos Santos-Neto
Journal:  J Bras Pneumol       Date:  2015 Jan-Feb       Impact factor: 2.624

Review 5.  Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.

Authors:  Bas C Mourik; Erik Lubberts; Jurriaan E M de Steenwinkel; Tom H M Ottenhoff; Pieter J M Leenen
Journal:  Front Immunol       Date:  2017-04-05       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.